‘Speculation Is Not Science’: Lupin Breezes Past Galderma On US Oracea Patents
Indian Firm Faces Immediate Appeal, After Originator Slammed By US District Court
Lupin received a more than favorable backing from a US district judge in Delaware, as the court shot down Galderma’s arguments that the Indian firm’s ANDA product would infringe two of its US Oracea patents.
